The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003920:Diabetes Mellitus / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D005260:Female; D005387:Finland; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007275:Injections, Intravenous; D007328:Insulin / Q000627:therapeutic use; D007538:Isoniazid / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D008297:Male; D008722:Methods; D008875:Middle Aged; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000378:metabolism*
D007004:Hypoglycemic Agents; D007328:Insulin; D007538:Isoniazid